跳至主要内容
临床试验/NCT02690467
NCT02690467Unknown不适用

Efficacy, Safety and Acceptability of the New Pen Needle 33G x 4 mm: a Cross-over Randomised Non Inferiority Trial

Center for Outcomes Research and Clinical Epidemiology, Italy6 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2016年9月6日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
80
试验地点
6
主要终点
Fructosamine levels

研究概览

简要总结

The purpose of this study is to determine the non-inferiority of a new Pic Insupen 34Gx3,5mm needle vs. a 32Gx4mm needle in terms of metabolic control, safety and acceptability in patients with diabetes treated with insulin.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with type 1 or type 2 diabetes
  • Age >= 18 years
  • Multiple daily injections of insulin for at least 6 months
  • Signed informed consent

排除标准

  • Pregnancy or or breast feeding
  • Inability to fill in the questionnaire
  • Combined therapy for diabetes (oral drugs associated with insulin injections)
  • Any medical condition that could interfere with the study according to the investigator's opinion

研究组 & 干预措施

Insupen G34x3,5mm

Experimental

Needle for insulin pen 3,5 mm long and with a diameter of 34 gauge

干预措施: Insupen G34x3,5mm (Device)

Insupen G32x4mm

Active Comparator

Needle for insulin pen 4 mm long and with a diameter of 32 gauge

干预措施: Insupen G32x4mm (Device)

结局指标

主要结局

Fructosamine levels

时间窗: 3 weeks

Change from baseline in fructosamine levels after 3 weeks of treatment

次要结局

  • Body weight(3 weeks)
  • Number of hypoglycaemia episodes(3 weeks)
  • Patient satisfaction measured by a questionnaire(3 weeks)
  • Number of episodes of insulin leakage at injection site(3 weeks)
  • Glycemic variability expressed as the standard deviation of fasting blood and postprandial glucose levels(3 weeks)
  • Daily insulin dose(3 weeks)
  • Number of patients with hypoglycaemia(3 weeks)
  • Pain(3 weeks)

研究者

发起方
Center for Outcomes Research and Clinical Epidemiology, Italy
申办方类型
Other
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验